Naoru Hamaguchi

This inventor holds 14 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 1985-2015.

USPTO Granted Patents = 14

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2

Average Co-Inventor Count = 3.1

ph-index = 8

Forward Citations = 367(Granted Patents)

Location History:

Ibaraki, JP (1989 - 2003)
Osaka, JP (1985 - 2015)

Company Filing History:

10 out of 1,858

Takeda Chemical Industries, Inc.

patents

4 out of 1,224

Takeda Pharmaceutical Company Limited

patents

Years Active: 1985-2015

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9101660 - Solid preparation (2015-08-11),

2. 8263121 - Solid pharmaceutical preparation (2012-09-11),

3. 7976853 - Process for producing coated preparation (2011-07-12),

4. 7700128 - Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester (2010-04-20),

5. 6568533 - Peelable package and peelable packaging method (2003-05-27),

6. 5888531 - Freeze-dried preparation for pharmaceutical use (1999-03-30),

7. 5643564 - Glycosylated cytokines (1997-07-01),

8. 5536735 - Pharmaceutical composition (1996-07-16),

9. 5080904 - Liposome composition and its production (1992-01-14),

10. 5019394 - Liposome composition and its production (1991-05-28),

11. 5000959 - Liposome composition and production thereof (1991-03-19),

12. 4877561 - Method of producing liposome (1989-10-31),

13. 4844904 - Liposome composition (1989-07-04),

14. 4497809 - Cephalosporin derivatives (1985-02-05),

Title: Naoru Hamaguchi: Innovator in Pharmaceutical Preparations

Introduction

Naoru Hamaguchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid preparations for diabetes treatment. With a total of 14 patents to his name, Hamaguchi's work has had a substantial impact on therapeutic drug formulations.

Latest Patents

Hamaguchi's latest patents focus on innovative solid preparations that contain insulin sensitizers and active ingredients. One of his notable inventions provides a solid preparation that is useful as a therapeutic drug for diabetes, showcasing superior characteristics such as content uniformity and dissolution properties. Another patent presents a solid pharmaceutical preparation that mimics the in vivo dissolution behavior of an insulin sensitizer, ensuring effective delivery of the active ingredients. These advancements highlight his commitment to improving drug formulations for better patient outcomes.

Career Highlights

Throughout his career, Naoru Hamaguchi has worked with esteemed companies such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective therapeutic solutions.

Collaborations

Hamaguchi has collaborated with notable colleagues, including Katsumi Iga and Yasuaki Ogawa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Naoru Hamaguchi's contributions to the field of pharmaceuticals, particularly in solid preparations for diabetes treatment, demonstrate his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing therapeutic solutions for patients in need.